Marijuana: Neurobiologic Correlates of Age of Onset
Marijuana: Neurobiologic Correlates of Age of Onset
批准号:
8304585
负责人:
STACI A GRUBER
金额:
$33.28万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2012
资助国家:
美国
项目状态:
已结题
起止时间:
2012-05-01 至 2017-03-31
关键词:
AbstinenceAgeAge of OnsetAnisotropyAnteriorAwarenessBehavioralBiological MarkersBrainChronicClinicalCognitiveComplementDataDependenceDevelopmentDiffusion Magnetic Resonance ImagingDrug usageExperimental DesignsFiberFrequenciesFrightFunctional Magnetic Resonance ImagingIllicit DrugsImaging TechniquesImpulsivityIndividualInvestigationLightMarijuanaMarijuana AbuseMarijuana SmokingMeasuresMedicalNeurocognitiveNeurophysiology - biologic functionPatternPerformancePersonalityPharmaceutical PreparationsPopulationPublic HealthPublic PolicyRecoveryRecovery of FunctionRelative (related person)ReportingRiskSeriesServicesSignal TransductionSmokeSmokerSmokingStructureTestingWorkcingulate cortexearly onsetexecutive functionfallsfrontal lobeimpressioninnovationnon-smokingnovelresearch studyresponsesmoking cessationtreatment strategytwelfth gradewhite matteryoung adult
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Marijuana (MJ) remains the most widely used illicit substance, with more than 16.7 million past month users. While the number of people who smoke MJ continues to rise each year, the average age of first regular use continues to fall, as does the percentage of individuals who perceive the use of MJ as risky or dangerous. This is perhaps not surprising in light of the ongoing debate regarding legalizing marijuana and the use of medical marijuana. Several investigations have reported alterations in chronic, heavy MJ smokers on frontal/ executive measures of cognitive performance, patterns of cortical activity as measured by functional magnetic resonance imaging (fMRI), and on measures of white matter microstructure relative to non-smoking control subjects. However, few have directly examined the neurobiologic impact of age of onset of MJ use in conjunction with these measures or the possibility of recovery of function following an extended period of abstinence. Our recent work highlighted the impact of age of onset of MJ use on both frequency and magnitude of MJ use, and found 1) significantly higher total number of smokes and amount (grams) of MJ smoked per week, 2) significant decreases in executive function and 3) alterations in brain activation patterns in early vs. late onset smokers. We have also reported alterations in diffusion tensor imaging (DTI) measures of frontal white matter which correlated with measures of impulsivity. We propose a novel experimental design that examines the extent to which age of onset of first regular MJ use is associated with decrements in executive function, alterations in neural function and microstructural white matter measures in chronic heavy MJ smokers who are defined as early onset (1st regular use prior to age 16) or late onset (1st regular use after age 16). We will also examine the potential for recovery of function by examining a group of former heavy MJ smokers who have abstained from use for a minimum of 2 years and a group of non-MJ smoking control subjects. We will apply BOLD fMRI and DTI to measure differences in brain activation and white matter fiber tract integrity in young adult subjects (18-30 years) with chronic, heavy MJ use who started smoking early, late or are former heavy MJ smokers or controls, and administer a battery of neurocognitive measures of executive function, as well as measures of clinical state, impulsivity, and personality. The proposed series of experiments utilizes an innovative combination of imaging techniques and neurocognitive tasks to collect key information that could ultimately identify biomarkers for vulnerability to MJ abuse or dependence. In addition, data regarding recovery of function following extended abstinence could be used to modify current public service messages and increase public awareness; the "this is your brain, this is your brain on drugs" message could be amended to include a message of hope - "and this is your brain after you stop using drugs" which may facilitate treatment strategies for those under the impression that the damage is already done. .
PUBLIC HEALTH RELEVANCE: Marijuana (MJ) remains the most widely used illicit drug with more than 16.7 million past month users, and while the number of people who smoke MJ rises each year, the average age of first regular use continues to fall, as does the percentage of people who think of MJ as risky or dangerous. Chronic, heavy MJ smokers have impaired cognitive abilities and altered brain activity and structure, but it is unknown how age of onset of
MJ use actually impacts these measures and importantly, if they recover after smoking stops. Data from this study will document the effects of MJ exposure during a period of developmental vulnerability on brain structure and function, and reveal possibilities for recovery following abstinence that may allow us to modify current public service messages and increase public awareness; the "this is your brain, this is your brain on drugs" message could be amended to include a message of hope - "and this is your brain after you stop using drugs" which may facilitate treatment strategies for those under the impression that the damage is already done.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Highs or Lows? Evaluating the Benefits and Consequences of Medical Marijuana Use in Older Adults with Chronic Pain and Opioid Use
-
批准号:10450065
-
项目类别:
-
资助金额:$41.0万
-
财政年份:2019
-
负责人:STACI A GRUBER
-
依托单位:
Highs or Lows? Evaluating the Benefits and Consequences of Medical Marijuana Use in Older Adults with Chronic Pain and Opioid Use
-
批准号:10025583
-
项目类别:
-
资助金额:$41.0万
-
财政年份:2019
-
负责人:STACI A GRUBER
-
依托单位:
Highs or Lows? Evaluating the Benefits and Consequences of Medical Marijuana Use in Older Adults with Chronic Pain and Opioid Use
-
批准号:10207583
-
项目类别:
-
资助金额:$41.0万
-
财政年份:2019
-
负责人:STACI A GRUBER
-
依托单位:
Highs or Lows? Evaluating the Benefits and Consequences of Medical Marijuana Use in Older Adults with Chronic Pain and Opioid Use
-
批准号:9797478
-
项目类别:
-
资助金额:$40.68万
-
财政年份:2019
-
负责人:STACI A GRUBER
-
依托单位:
Marijuana: Neurobiologic Correlates of Age of Onset
-
批准号:8644793
-
项目类别:
-
资助金额:$46.81万
-
财政年份:2012
-
负责人:STACI A GRUBER
-
依托单位:
Marijuana: Neurobiologic Correlates of Age of Onset
-
批准号:8458055
-
项目类别:
-
资助金额:$44.68万
-
财政年份:2012
-
负责人:STACI A GRUBER
-
依托单位:
Imaging Data in Emerging Adults with Addiction (IDEAA): McLean Hospital Site
-
批准号:8527905
-
项目类别:
-
资助金额:$12.75万
-
财政年份:2012
-
负责人:STACI A GRUBER
-
依托单位:
Marijuana and Mood: Frontal Predictors of Behavior
-
批准号:7491608
-
项目类别:
-
资助金额:$13.15万
-
财政年份:2007
-
负责人:STACI A GRUBER
-
依托单位:
Marijuana and Mood: Frontal Predictors of Behavior
-
批准号:7305421
-
项目类别:
-
资助金额:$25.49万
-
财政年份:2007
-
负责人:STACI A GRUBER
-
依托单位:
Frontal Neural Mechanisms and Risk for Substance Abuse
-
批准号:6674640
-
项目类别:
-
资助金额:$20.57万
-
财政年份:2003
-
负责人:STACI A GRUBER
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: